‘Living medicine’ created to tackle drug-resistant lung infections
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
On Tuesday, 17 January 2023, the IDIBAPS auditorium was the venue for the Second Conference on Good Practice of the Network of Tumour Banks of Catalo1
Endowed with eight million euros, the project is coordinated by Susana Puig, the head of the research group IDIBAPS Melanoma: imaging, genetics and i1
IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders t1
The results contrast with those of 4 previous independent clinical trials and could provide relevant information on the role of iron accumulation in1
Non-alcoholic or low-alcohol beverages can have a negative impact on people with an alcohol use disorder. This was suggested by a systematic review c1
The Members’ General Meeting, held to coincide with the Society’s 16th Congress which took place on 24 and 25 November, approved the appointment.
The spin-off helmed by Aleix Prat received the award in the category of Collaborative Research in Transfer for Development for its HER2DX breast canc1
Researchers from the CAPSBE and from IDIBAPS have shown that older adults have difficulty in making use of tele-consult services, and that the increa1